Vivos Therapeutics, Inc. (VVOS) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Vivos Therapeutics, Inc. (VVOS:NASDAQ), powered by AI.

Current Price
$0.54
Sector
Healthcare
What is the Vivos Therapeutics, Inc. stock price forecast?

Vivos Therapeutics, Inc. is currently trading at $0.54. View real-time AI analysis on Alpha Lenz.

What is Vivos Therapeutics, Inc. insider trading activity?

View the latest insider trading data for Vivos Therapeutics, Inc. on Alpha Lenz.

What is Vivos Therapeutics, Inc.'s P/E ratio?

View Vivos Therapeutics, Inc.'s valuation metrics on Alpha Lenz.

Vivos Therapeutics, Inc.

NASDAQ · VVOS
$0.54-0.03(-5.63%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Vivos Therapeutics, Inc.'s future dividend policy...
Alpha Chat Insight

Vivos Therapeutics, Inc.'s ROE is -656.9%. Explore profitability and growth together.

Ask for details

Company Overview

Vivos Therapeutics, Inc. is a medical technology company that concentrates on addressing sleep apnea through innovative treatment solutions. Primarily known for its proprietary systems and devices, the company offers a non-surgical approach designed to improve airway function and alleviate symptoms for patients suffering from obstructive sleep apnea (OSA), a common and often undiagnosed condition linked to various health issues. Operating at the intersection of medical devices and dental care, Vivos provides its solutions primarily to healthcare professionals, enabling them with tools and training necessary to effectively manage and treat sleep disorders. This focus on a non-invasive methodology has positioned Vivos as a notable player in the sleep disorder treatment market. Its approach not only aims to provide relief for individuals but also reduces dependency on traditional continuous positive airway pressure (CPAP) machines. Vivos Therapeutics plays a significant role in enhancing patient care within the healthcare sector by bridging the gap between dentistry and medicine, helping to raise awareness and offer alternative treatments for sleep-related breathing disorders.

CEOMr. R. Kirk Huntsman
SectorHealthcare
IndustryMedical Devices
Employees113

Company Statistics

FY 2025

Profile

N/AMarket Cap
$17.44MRevenue
0.00Shares Out
113Employees

Margins

60.44%Gross
-106.55%EBITDA
-114.05%Operating
-121.71%Pre-Tax
-121.71%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

2.87%Rev 3Yr
5.95%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-105.01%ROA
-656.87%ROE
-98.40%ROIC

Financial Health

$2.03MCash & Cash Equivalents
$24.67MNet Debt
-1722.71%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Vivos Therapeutics, Inc. (ticker: VVOS) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 113 employees.

The current price is $0.545 with a P/E ratio of -x and P/B of -x.

ROE is -656.87% and operating margin is -114.05%. Annual revenue is $17M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Vivos Therapeutics, Inc. (VVOS) Stock Forecast 2026 $0.54 — Price, Financials & Analyst Targets | Alpha Lenz